Randox Biosciences customisation service which encompasses antibodies and recombinant proteins has achieved tremendous success within the biopharmaceutical and diagnostic industries. Key components of our custom service are our range of monoclonal antibodies as well as our recombinant antibody fragments (scFv’s, fAb’s, sdAb’s).
Our scientists highly recommend the use of Single Domain Antibody Fragments (sdAb) as they are more stable, adaptable and easily humanised, making them ideal for therapeutic products. SdAb’s provide a new mechanism for the generation of antibody therapeutics and offer numerous advantages such as better tissue penetration, ease of expression, stability and uniformity of product. SdAb’s also have benefits in traditional diagnostic settings, due to their small size, a much higher coating concentration can be achieved for assay development.